Conditions: Obesity
Keywords: gastric bypass surgery
Allocation: NA | Intervention model: SINGLE_GROUP
Enrollment: 19
Healthy volunteers: no

Brief summary:
The primary goal of the study is to determine if orlistat 60mg (Alli) is effective in helping patients achieve a required 10% weight loss goal prior to bariatric surgery. The medication will be added to the usual standard of care which includes education regarding diet and exercise and monthly meetings with a registered dietician.

Detailed description:

Arms:
arm 1: Patients assigned to treatment group for up to 6 months of therapy.

Interventions: intervention 1: Orlistat
Intervention descriptions: intervention 1: 60mg capsule three times a day for up to 6 months

Protocol document: